Century Therapeutics to Present at Upcoming Investor Conferences
Century Therapeutics (NASDAQ: IPSC) announced participation in key investor conferences in May 2022. The management team will engage in a fireside chat at the Bank of America Securities 2022 Healthcare Conference on May 10 at 8:40 AM PT, and present at the H.C. Wainwright Global Investment Conference on May 24, available on-demand from 7:00 AM ET. Replays of these events will be accessible for 30 days on the Company’s website. Century focuses on iPSC-derived cell therapies for cancer treatment.
- None.
- None.
PHILADELPHIA, May 03, 2022 (GLOBE NEWSWIRE) -- Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in immuno-oncology, today announced that members of the management team will participate in the following investor conferences in May:
- The Bank of America Securities 2022 Healthcare Conference. The fireside chat will take place at 8:40 AM PT/ 11:40 AM ET on Tuesday, May 10, 2022.
- The H.C. Wainwright Global Investment Conference. The presentation will be available on-demand beginning at 7:00 AM ET on Tuesday, May 24, 2022.
A replay of the events will be available on the “Events & Presentations” page in the “Investors” section of the Company’s website at https://investors.centurytx.com/events-and-presentations and will be available for 30 days following the events.
About Century Therapeutics
Century Therapeutics (NASDAQ: IPSC) is harnessing the power of adult stem cells to develop curative cell therapy products for cancer that we believe will allow us to overcome the limitations of first-generation cell therapies. Our genetically engineered, iPSC-derived iNK and iT cell product candidates are designed to specifically target hematologic and solid tumor cancers. We are leveraging our expertise in cellular reprogramming, genetic engineering, and manufacturing to develop therapies with the potential to overcome many of the challenges inherent to cell therapy and provide a significant advantage over existing cell therapy technologies. We believe our commitment to developing off-the-shelf cell therapies will expand patient access and provide an unparalleled opportunity to advance the course of cancer care. For more information on Century Therapeutics please visit www.centurytx.com.
Century Therapeutics Forward-Looking Statement
This press release contains forward-looking statements within the meaning of, and made pursuant to the safe harbor provisions of, The Private Securities Litigation Reform Act of 1995. In some cases, you can identify forward-looking statements by terms such as “may,” “might,” “will,” “should,” “expect,” “plan,” “aim,” “seek,” “anticipate,” “could,” “intend,” “target,” “project,” “contemplate,” “believe,” “estimate,” “predict,” “forecast,” “potential” or “continue” or the negative of these terms or other similar expressions. These statements are not guarantees of future performance These risks and uncertainties are described more fully in the “Risk Factors” section of our most recent filings with the Securities and Exchange Commission and available at www.sec.gov. You should not rely on these forward-looking statements as predictions of future events. The events and circumstances reflected in our forward-looking statements may not be achieved or occur, and actual results could differ materially from those projected in the forward-looking statements. Except as required by applicable law, we do not plan to publicly update or revise any forward-looking statements contained herein, whether as a result of any new information, future events, changed circumstances or otherwise.
For More Information:
Company: Elizabeth Krutoholow – investor.relations@centurytx.com
Investors: Melissa Forst/Maghan Meyers – century@argotpartners.com
Media: Joshua R. Mansbach – century@argotpartners.com
FAQ
What are the upcoming investor conferences for Century Therapeutics in May 2022?
When is the Bank of America Securities Healthcare Conference for Century Therapeutics?
When will the presentation be available for the H.C. Wainwright Global Investment Conference?
How can I access the replays of Century Therapeutics' investor conferences?
What is the focus of Century Therapeutics' cell therapy development?
